Status:
COMPLETED
Compass Course: COVID-19
Lead Sponsor:
Allina Health System
Conditions:
COVID-19
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
A group of clinicians and researchers developed an 8-session group intervention that integrates education, support, self-reflection, and action-expectation to help people reaffirm or reconstruct self-...
Eligibility Criteria
Inclusion
- 18 - 80 years of age;
- Are part of the Allina Health COVID Research Registry or are receiving/have received therapy services for COVID-19 related sequelae at CKRI;
- English speaking
- Graduated from high school
- Able to see, hear, speak (with or without assistive devices)
- Access to computer or tablet and adequate internet connection to participate in video conference
- Has an email address;
- Own a smartphone with one of the following operating system versions:
- iOS 9.0 - 9.3, 10.0 - 10.3, 12, 13.3, 13.7, 14.0 - 14.4 or later Android 8.0 - 8.1.0, 9, 10, 11 or later
- Agree to use personal smartphone to download mEMA application and respond to application notifications (mEMA is described in Sections 3.2.3.1 and 3.2.4.2.2);
- Willing and able to commit to attend all intervention sessions
Exclusion
- History of neurologic disorder (such as stroke or brain injury) with residual impairments that likely interfere with learning;
- Any medical condition (physical or mental health) that interferes with the performance of everyday activities and roles.
Key Trial Info
Start Date :
March 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2024
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05295238
Start Date
March 7 2022
End Date
January 22 2024
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States, 55447